期刊文献+

CIDP的一个重要的疗效和预后判断分类系统:CIDP病情活动性状况 被引量:1

在线阅读 下载PDF
导出
摘要 对于慢性炎症性脱髓鞘性多神经病(CIDP)这样的慢性疾病,如何进行长期治疗后的预后判断是一个挑战性问题。当代循证医学需要在大样本量基础上有临床试验或前瞻性或回顾性病例注册研究证据来支持,尤其是CIDP这样的少见疾病。在过去的CIDP研究中,不同研究者采用了不同的疗效定义对不同样本量的患者进行了评价,
作者 李海峰 高翔
出处 《中国神经免疫学和神经病学杂志》 CAS 北大核心 2013年第4期293-295,共3页 Chinese Journal of Neuroimmunology and Neurology
  • 相关文献

参考文献9

  • 1Gorson KC, Allam G, Ropper AH. Chronic inflammatory de myelinating polyneuropathy: clinical features and response to treatment in 67 consecutive palients with and without a mono clonalgammopathy[J]. Neurology, 1997, 48: 321-328.
  • 2Tackenberg B, I.unemann JD, Steinbrecher A, et al. Classifi- cations and treatment responses in chronic immune-mediated demyelinating polyneuropathy[J]. Neurology, 2007, 68:1622-1629.
  • 3Merkies IS, Schmitz PI, van der Meche FG, et al. Clinimetric evaluation of a new overall disability scale in immune mediated polyneuropathies[J]. J Neurol Neurosurg Psychiatry, 2002, 72:596-601.
  • 4Kuwabara S, Misawa S, Mori M, el al. Long term prognosis of chronic inflammatory demyelinating polyneuropathy: a five year follow up of 38 cases[J]. J Neurol Neurosurg Psychiatry, 2006, 77:66 -70.
  • 5Graham RC, Hughes RA. A modified peripheral neuropathy scale= the Overall Neuropathy Limitations Scale[J]. J Neurol Neurosurg Psychiatry, 2006, 77:973 -976.
  • 6Hughes RA, Donofrio P, Bril V, et al. Intravenous immune globulin (10%caprylatechromatography purified) for the treatment of chronic inflammatory demyelinating polyradiculo neuropathy (ICE study) : a randomised placebo controlled trial [J]. Lancet Neurol, 2008, 7:136- 144.
  • 7van Schaik IN, Eftimov F, van Doorn PA, et al. Pulsed high dose dexamethasone versus standard prednisolone treatment for chronic inflammatory demyelinating polyradiculoneuropa thy(PREDICT study) : a double-blind, randomised, controlled trial[J]. Lancet Neurol, 2010, 9: 245-253.
  • 8Jaretzki A 3rd, Barohn RJ, Ernstoff RM, et al. Myasthenia gravist recommendations for clinical research standards. Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America[J]. Neurology, 2000, 55: 16-23.
  • 9Gorson KC, van Schaik IN, Merkies IS, et al. Chronic in flammatory demyelinating polyneuropathy disease activity sta- tus: recommendations for clinical research standards and use in clinical practice[J]. J Peripher Nerv Syst, 2010, 15: 326-333.

同被引文献6

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部